168 related articles for article (PubMed ID: 35682939)
41. Prospects for Venetoclax in Myelodysplastic Syndromes.
Garcia JS
Hematol Oncol Clin North Am; 2020 Apr; 34(2):441-448. PubMed ID: 32089221
[TBL] [Abstract][Full Text] [Related]
42. Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.
Izutsu K; Yamamoto K; Kato K; Ishikawa T; Fukuhara N; Terui Y; Choi I; Humphrey K; Kim SY; Okubo S; Ogawa N; Nishimura Y; Salem AH; Maruyama D
Int J Hematol; 2021 Mar; 113(3):370-380. PubMed ID: 33094474
[TBL] [Abstract][Full Text] [Related]
43. Protective effect of Di'ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity.
Li X; Liang J; Qin A; Wang T; Liu S; Li W; Yuan C; Qu L; Zou W
J Ethnopharmacol; 2022 Apr; 287():114943. PubMed ID: 34954266
[TBL] [Abstract][Full Text] [Related]
44. Pantoprazole Attenuates MAPK (ERK1/2, JNK, p38)-NF-κB and Apoptosis Signaling Pathways after Renal Ischemia/Reperfusion Injury in Rats.
Fawzy MA; Maher SA; Bakkar SM; El-Rehany MA; Fathy M
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639009
[TBL] [Abstract][Full Text] [Related]
45. Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Huemer F; Melchardt T; Jansko B; Wahida A; Jilg S; Jost PJ; Klieser E; Steiger K; Magnes T; Pleyer L; Greil-Ressler S; Rass C; Greil R; Egle A
Eur J Haematol; 2019 May; 102(5):437-441. PubMed ID: 30725494
[TBL] [Abstract][Full Text] [Related]
46. Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations.
Birkinshaw RW; Gong JN; Luo CS; Lio D; White CA; Anderson MA; Blombery P; Lessene G; Majewski IJ; Thijssen R; Roberts AW; Huang DCS; Colman PM; Czabotar PE
Nat Commun; 2019 Jun; 10(1):2385. PubMed ID: 31160589
[TBL] [Abstract][Full Text] [Related]
47. Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways.
Imam F; Al-Harbi NO; Al-Harbi MM; Ansari MA; Al-Asmari AF; Ansari MN; Al-Anazi WA; Bahashwan S; Almutairi MM; Alshammari M; Khan MR; Alsaad AM; Alotaibi MR
Pharmacol Rep; 2018 Oct; 70(5):993-1000. PubMed ID: 30118964
[TBL] [Abstract][Full Text] [Related]
48. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.
Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W
J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141
[TBL] [Abstract][Full Text] [Related]
49. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
Abdel-Daim MM; Kilany OE; Khalifa HA; Ahmed AAM
Cancer Chemother Pharmacol; 2017 Oct; 80(4):745-753. PubMed ID: 28785995
[TBL] [Abstract][Full Text] [Related]
50. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E
Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133
[TBL] [Abstract][Full Text] [Related]
51. Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1.
Teh TC; Nguyen NY; Moujalled DM; Segal D; Pomilio G; Rijal S; Jabbour A; Cummins K; Lackovic K; Blombery P; Thompson E; Ekert PG; Lessene G; Glaser SP; Huang DCS; Roberts AW; Guthridge MA; Wei AH
Leukemia; 2018 Feb; 32(2):303-312. PubMed ID: 28751770
[TBL] [Abstract][Full Text] [Related]
52. Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclax.
Marques-Piubelli ML; Schlette EJ; Khoury JD; Furqan F; Vega F; Soto LMS; Wistuba II; Wierda WG; Konopleva M; Ferrajoli A; Strati P
Leuk Lymphoma; 2021 May; 62(5):1129-1135. PubMed ID: 33327833
[TBL] [Abstract][Full Text] [Related]
53. Alginate Oligosaccharide Prevents Acute Doxorubicin Cardiotoxicity by Suppressing Oxidative Stress and Endoplasmic Reticulum-Mediated Apoptosis.
Guo JJ; Ma LL; Shi HT; Zhu JB; Wu J; Ding ZW; An Y; Zou YZ; Ge JB
Mar Drugs; 2016 Dec; 14(12):. PubMed ID: 27999379
[TBL] [Abstract][Full Text] [Related]
54. Clozapine-Induced Cardiotoxicity: Role of Oxidative Stress, Tumour Necrosis Factor Alpha and NF-κβ.
Abdel-Wahab BA; Metwally ME
Cardiovasc Toxicol; 2015 Oct; 15(4):355-65. PubMed ID: 25539628
[TBL] [Abstract][Full Text] [Related]
55. Diallyl trisulfide suppresses doxorubicin-induced cardiomyocyte apoptosis by inhibiting MAPK/NF-κB signaling through attenuation of ROS generation.
Wen SY; Tsai CY; Pai PY; Chen YW; Yang YC; Aneja R; Huang CY; Kuo WW
Environ Toxicol; 2018 Jan; 33(1):93-103. PubMed ID: 29087013
[TBL] [Abstract][Full Text] [Related]
56. The role of GSH in microcystin-induced apoptosis in rat liver: Involvement of oxidative stress and NF-κB.
Chen L; Li S; Guo X; Xie P; Chen J
Environ Toxicol; 2016 May; 31(5):552-60. PubMed ID: 25410294
[TBL] [Abstract][Full Text] [Related]
57. Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia.
Del Poeta G; Postorino M; Pupo L; Del Principe MI; Dal Bo M; Bittolo T; Buccisano F; Mariotti B; Iannella E; Maurillo L; Venditti A; Gattei V; de Fabritiis P; Cantonetti M; Amadori S
Drugs Today (Barc); 2016 Apr; 52(4):249-60. PubMed ID: 27252989
[TBL] [Abstract][Full Text] [Related]
58. Quercetin Attenuates Manganese-Induced Neuroinflammation by Alleviating Oxidative Stress through Regulation of Apoptosis, iNOS/NF-κB and HO-1/Nrf2 Pathways.
Bahar E; Kim JY; Yoon H
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914791
[TBL] [Abstract][Full Text] [Related]
59. A literature review of the patent publications on venetoclax - a selective Bcl-2 inhibitor: discovering the therapeutic potential of a novel chemotherapeutic agent.
Žigart N; Časar Z
Expert Opin Ther Pat; 2019 Jul; 29(7):487-496. PubMed ID: 31154862
[TBL] [Abstract][Full Text] [Related]
60. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.
Alsaad AM; Zordoky BN; El-Sherbeni AA; El-Kadi AO
Drug Metab Dispos; 2012 Nov; 40(11):2126-35. PubMed ID: 22867862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]